Sign In
Buy STTK
$7.92
+0.630 (+8.64%)
At Close: Aug 04, 2026
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights
06:15am, Thursday, 05'th Mar 2026
AUSTIN, Texas and DURHAM, N.C., March 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of po
Shattuck Labs Announces Participation in Upcoming March Investor Conferences
08:00am, Wednesday, 25'th Feb 2026
AUSTIN, TX and DURHAM, NC, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-cl
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $6.20 Consensus PT from Analysts
04:08am, Sunday, 08'th Feb 2026
Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) has earned a consensus rating of "Hold" from the seven research firms that are covering the stock, Marketbeat Ratings reports. One equities researc
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
08:30am, Friday, 06'th Feb 2026
AUSTIN, TX and DURHAM, NC, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targ
Shattuck Labs, Inc. (NASDAQ:STTK) Sees Large Growth in Short Interest
02:54am, Sunday, 01'st Feb 2026
Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) was the target of a large increase in short interest in January. As of January 15th, there was short interest totaling 2,198,677 shares, an increas
Why Shattuck Labs Stock Soared in December
10:30pm, Monday, 05'th Jan 2026
An analyst's recommendation upgrade had a major impact on investor sentiment. It's now a buy, according to the pundit.
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Monday, 15'th Dec 2025
AUSTIN, TX and DURHAM, NC, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development
Analyst Upgrade Boosts Shattuck On Confidence In Next-Gen Inflammatory Bowel Disease Therapy
04:33pm, Monday, 01'st Dec 2025
HC Wainwright upgraded Shattuck Labs Inc. (NASDAQ: STTK) from Neutral to Buy, with a price forecast of $6. The company's lead product candidate, SL-325, is a DR3 antagonist antibody for inflammatory b
Shattuck Labs to Participate in Upcoming December Investor Conferences
08:00am, Thursday, 20'th Nov 2025
AUSTIN, TX and DURHAM, NC, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development
Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights
04:30pm, Thursday, 06'th Nov 2025
–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers – – Closed a private placement of up to $103 million in August 2025 to support advancement of SL-325 – – A
Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript
09:16pm, Friday, 10'th Oct 2025
Shattuck Labs, Inc. (NASDAQ:STTK ) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT Company Participants Taylor Schreiber - Co-Founder, CEO & Director Con
What Makes Shattuck Labs, Inc. (STTK) a Strong Momentum Stock: Buy Now?
01:01pm, Wednesday, 08'th Oct 2025
Does Shattuck Labs, Inc. (STTK) have what it takes to be a top stock pick for momentum investors? Let's find out.
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel
07:51am, Thursday, 02'nd Oct 2025
AUSTIN, TX and DURHAM, NC, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor nec
Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?
10:55am, Friday, 19'th Sep 2025
Shattuck Labs, Inc. (STTK) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, STTK's 50-day simple moving average crossed above
Shattuck Labs (STTK) Upgraded to Buy: What Does It Mean for the Stock?
06:10pm, Monday, 08'th Sep 2025
Shattuck Labs (STTK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
